Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Viemed Healthcare Narrows FY2025 Sales Guidance from $271.000M-$277.000M to $271.000M-$273.000M vs $267.050M Est

Author: Benzinga Newsdesk | November 05, 2025 04:43pm
Viemed Healthcare (NASDAQ:VMD) narrows FY2025 sales outlook from $271.000 million-$277.000 million to $271.000 million-$273.000 million vs $267.050 million estimate.

Posted In: VMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist